Aashka Hospitals MoU for 70% Rhythm stake in 2026

What Aashka Hospitals announced

Aashka Hospitals Limited disclosed two connected strategic steps aimed at expanding its healthcare footprint through a new structure with the Rhythm Group’s healthcare businesses. On August 7, 2026, the company entered into a Memorandum of Understanding (MoU) to acquire a 70% controlling stake in a newly formed entity that will house four Rhythm Group healthcare operations. Separately, the Board of Directors approved an investment in a proposed subsidiary, Aashka – Rhythm Hospitals Private Limited, to secure 70% control through a cash subscription.

Both disclosures were made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as part of its compliance framework. The announcements are structured around majority voting rights and board control rather than a simple financial investment.

MoU dated August 7: 70% control in a newly formed entity

Under the MoU executed on August 7, 2026, Aashka Hospitals agreed to acquire a 70% controlling stake in a newly formed entity that will consolidate four Rhythm Group healthcare businesses into one corporate structure. The businesses identified in the disclosure are Rhythm Medical Stores, Rhythm Multispeciality Hospital, Cardioplus Heart Care, and Rhythm Medical & Heart Hospital. Aashka said the consolidation would give it majority voting rights and board control in the new structure.

The disclosure states that the company will acquire 70% equity shares from existing shareholders of the newly emerged entity. Importantly, Aashka clarified that no shares are being issued to it at this stage, and the transaction is framed as a purchase of existing equity rather than an issuance. The purchase price is to be determined through valuation on the transaction date, and no monetary consideration was disclosed in the MoU announcement.

Aashka also stated that there was no primary relationship between the parties prior to the agreement, meaning the transaction did not fall within the definition of a related-party transaction at the time of signing. However, it also noted that upon completion of the restructuring, the newly emerged company will become a related party to Aashka Hospitals.

Control and governance rights under the MoU

The MoU is positioned as a controlling acquisition, not a passive stake. Aashka disclosed that the arrangement provides it with majority decision-making power and board control. It also grants Aashka the right to appoint directors and restrict changes in the capital structure of the new entity, which are typical protections when a buyer seeks operating control.

The filing additionally mentions that the agreement does not involve loan agreements or nominee disclosures that would create potential conflicts of interest. This is relevant for investors assessing governance risks, especially where restructuring and consolidation are involved. The company’s description of the structure emphasises governance rights alongside the stake percentage.

Board approval dated July 28: proposed subsidiary with ₹0.0007 crore investment

In a separate disclosure, Aashka Hospitals said its Board authorised an investment in a newly proposed subsidiary, Aashka – Rhythm Hospitals Private Limited. The board approval was granted during a meeting held on July 28, 2026. The meeting commenced at 17:00 hours and concluded at 18:00 hours.

The proposed investment is a cash consideration of ₹0.0007 crore (₹70,000), structured as subscription to 7,000 equity shares with a face value of ₹10 each. The subscription is intended to give Aashka a 70% stake, along with voting rights and control over the proposed subsidiary. The company stated the subsidiary is yet to be incorporated and will be domiciled in India.

The disclosure also stated that no specific governmental or regulatory approvals are required for the incorporation of the proposed subsidiary. The entity will operate within the regulatory framework governing hospitals and healthcare activities in India.

How the Rhythm businesses are being consolidated

A key feature of the August 7 MoU is the stated intent to bring multiple Rhythm Group healthcare businesses into a single corporate structure. The businesses listed span medical stores and hospital facilities, including speciality care through Cardioplus Heart Care. Aashka framed the step as an expansion that enables it to integrate multiple specialty facilities under one umbrella.

From a transaction design perspective, the structure described involves a “newly formed entity” that will hold the consolidated operations. Aashka’s 70% stake is intended to translate into majority voting rights and board control at the consolidated entity level, rather than separate minority positions in each underlying business.

Key disclosed terms at a glance

Stock and company context disclosed alongside the filing

The article information also included market and company identifiers for Aashka Hospitals Limited. It lists the sector as Healthcare and the industry as Hospital & Healthcare Services, and references BSE scrip code 543346. It also states the company was incorporated in 2012 and operates multi-disciplinary private hospitals, clinics, and pharmacies.

The same dataset mentions a current price of ₹80.0 and a bid/ask of 66.25 / 81.00. These figures were presented as part of the company snapshot and not as a commentary on the transaction itself.

Market impact and what investors can infer from the disclosures

The central market-relevant point is the intended shift in control and operating structure. The August 7 MoU is framed as a control acquisition, with Aashka seeking majority voting rights, board control, and constraints over capital structure changes. But the purchase consideration is explicitly tied to a valuation on the transaction date and is not disclosed, indicating that final consideration depends on independent valuations yet to be finalised.

The July 28 board-approved investment is small in nominal terms at ₹0.0007 crore, but it is structured to deliver 70% ownership and control in a proposed subsidiary. Since the subsidiary is yet to be incorporated, this disclosure is more about organisational setup and governance than immediate operating scale.

Conclusion

Aashka Hospitals has outlined a two-part expansion plan: an MoU to acquire 70% control in a newly formed entity consolidating four Rhythm healthcare businesses, and a board-approved 70% investment in a proposed subsidiary through a ₹0.0007 crore equity subscription. The MoU price remains dependent on valuation at the transaction date, while the subsidiary incorporation is proceeding without specific governmental or regulatory approvals. Next milestones will depend on completion of the restructuring referenced in the MoU and incorporation of Aashka – Rhythm Hospitals Private Limited.